109 related articles for article (PubMed ID: 21530016)
1. Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs.
Daumar P; Decombat C; Chezal JM; Debiton E; Madesclaire M; Coudert P; Galmier MJ
Eur J Med Chem; 2011 Jul; 46(7):2867-79. PubMed ID: 21530016
[TBL] [Abstract][Full Text] [Related]
2. Short oligonucleotide prodrug having 5-fluoro and 5-iodouracil inhibits the proliferation of cancer cells in a photo-responsive manner.
Fujimoto K; Takematsu YK; Shigeno A; Furusawa M; Sakamoto T
Bioorg Med Chem Lett; 2014 Aug; 24(16):3736-8. PubMed ID: 25080163
[TBL] [Abstract][Full Text] [Related]
3. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
Li M; Liang Z; Sun X; Gong T; Zhang Z
PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
[TBL] [Abstract][Full Text] [Related]
4. Novel thermosensitive 5-fluorouracil-cyclotriphosphazene conjugates: synthesis, thermosensitivity, degradability, and in vitro antitumor activity.
Cho YW; Lee JR; Song SC
Bioconjug Chem; 2005; 16(6):1529-35. PubMed ID: 16287251
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of conjugates of 5-Fluorouracil and emodin.
Zhao LM; Zhang LM; Liu JJ; Wan LJ; Chen YQ; Zhang SQ; Yan ZW; Jiang JH
Eur J Med Chem; 2012 Jan; 47(1):255-60. PubMed ID: 22093761
[TBL] [Abstract][Full Text] [Related]
6. Sulfonyl-containing nucleoside phosphotriesters and phosphoramidates as novel anticancer prodrugs of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP).
Sun YW; Chen KM; Kwon CH
Mol Pharm; 2006; 3(2):161-73. PubMed ID: 16579645
[TBL] [Abstract][Full Text] [Related]
7. Selective bone targeting 5-fluorouracil prodrugs: synthesis and preliminary biological evaluation.
Ouyang L; He D; Zhang J; He G; Jiang B; Wang Q; Chen Z; Pan J; Li Y; Guo L
Bioorg Med Chem; 2011 Jun; 19(12):3750-6. PubMed ID: 21612935
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Bioactivity Assessment of Chitosan-1-Acetic Acid-5-Flurouracil Conjugates as Cancer Prodrugs.
Mohammed MO; Hussain KS; Haj NQ
Molecules; 2017 Nov; 22(11):. PubMed ID: 29117097
[TBL] [Abstract][Full Text] [Related]
9. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
Jin Y; Yang F; Du L
Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of new liver targeting 5-fluorouracil-cholic acid conjugates.
Qian S; Wu JB; Wu XC; Li J; Wu Y
Arch Pharm (Weinheim); 2009 Sep; 342(9):513-20. PubMed ID: 19598290
[TBL] [Abstract][Full Text] [Related]
11. Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent.
Jiang Y; Li X; Hou J; Huang Y; Jia Y; Zou M; Zhang J; Wang X; Xu W; Zhang Y
Eur J Med Chem; 2016 Oct; 121():649-657. PubMed ID: 27322756
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin nanoparticle mediated targeted delivery of 5-fluorouracil for enhanced therapeutic efficacy.
Kumari S; Kondapi AK
Int J Biol Macromol; 2017 Feb; 95():232-237. PubMed ID: 27864056
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Evaluation of a Conjugate of 5-Fluorouracil and an LSD1 Inhibitor.
Ota Y; Nakamura A; Elboray EE; Itoh Y; Suzuki T
Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):192-195. PubMed ID: 30369513
[TBL] [Abstract][Full Text] [Related]
14. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
15. A rapid albumin-binding 5-fluorouracil prodrug with a prolonged circulation time and enhanced antitumor activity.
Zhao D; Zhang H; Tao W; Wei W; Sun J; He Z
Biomater Sci; 2017 Feb; 5(3):502-510. PubMed ID: 28116362
[TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of capecitabine and its six metabolites in human plasma using liquid chromatography coupled to electrospray tandem mass spectrometry.
Deenen MJ; Rosing H; Hillebrand MJ; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan; 913-914():30-40. PubMed ID: 23270936
[TBL] [Abstract][Full Text] [Related]
17. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
Jain M; Fan J; Baturay NZ; Kwon CH
J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
[TBL] [Abstract][Full Text] [Related]
18. Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary
Salerno L; Vanella L; Sorrenti V; Consoli V; Ciaffaglione V; Fallica AN; Canale V; Zajdel P; Pignatello R; Intagliata S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1378-1386. PubMed ID: 34167427
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy.
Jiang Y; Li X; Hou J; Huang Y; Wang X; Jia Y; Wang Q; Xu W; Zhang J; Zhang Y
Eur J Med Chem; 2018 Jan; 143():334-347. PubMed ID: 29202398
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers.
Varshosaz J; Hassanzadeh F; Sadeghi H; Andalib S
Eur J Med Chem; 2012 Aug; 54():429-38. PubMed ID: 22687440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
